Travere Therapeutics can compound FILSPARI revenue through its expanding IgAN and FSGS franchise, but concentrated product exposure, dilution, and demanding commercial expectations limit its margin of safety.
TAL Education's operating recovery, substantial net cash, and low valuation offer upside potential, but Chinese education regulation and volatile investment-related earnings remain significant risks.
Twilio's expanding cash flow, stronger margins, and embedded communications platform support long-term value creation, but SBC, competitive pricing, and uncertainty over organic growth durability limit the margin of safety.
Telkom Indonesia offers a discounted, cash-generative telecommunications franchise with infrastructure monetization upside, although state-controlled governance, competitive pricing, and currency risk could limit shareholder returns.
TELUS owns a durable Canadian telecom franchise trading below historical cash-flow valuations, but heavy debt, weaker digital services economics, and the dividend reset make its recovery uncertain.
Trane Technologies combines a durable HVAC franchise, exceptional capital returns, and growing data-center cooling exposure, but its premium valuation and sensitivity to commercial construction demand require disciplined entry pricing.
Tradeweb combines a durable electronic fixed-income trading network, strong cash generation, and structural market growth, but premium valuation and the $1.97B Trumid acquisition create execution and downside risks.
TE Connectivity combines high-return engineered connectivity franchises with accelerating AI and power infrastructure demand at a reasonable valuation, although automotive cyclicality and acquisition execution remain important risks.
TotalEnergies combines strong cash generation, LNG growth opportunities and attractive shareholder distributions with a moderate valuation, although oil-price cyclicality and large-project execution risks constrain sustainable upside.
TowneBank offers a profitable Southeastern regional banking franchise with attractive tangible returns and merger-driven expansion, but acquisition dilution, rising problem loans, and uncertain normalized EPS growth limit near-term upside.
TransMedics is building a differentiated organ preservation and transplant logistics platform with significant long-term growth potential, but slowing revenue growth, margin compression, and capital-intensive expansion weaken its near-term investment appeal.
T-Mobile US combines nationwide 5G network advantages, rising wireless account monetization, and strong cash-funded shareholder returns with an attractive valuation, although heavy debt and competitive pressure remain important risks.